RIADH KHARRAT

Dr. RIADH KHARRAT


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Oussema KhamessiOussema Khamessi
Oussema Khamessi
HMHazem Ben Mabrouk
Hazem Ben Mabrouk
RERym ElFessi-Magouri
Rym ElFessi-Magouri
RKRIADH KHARRAT
RIADH KHARRAT

1 July 2018 in Toxicon
Verified
Journal Article
Closed access
RMRiadh Maatoug
Riadh Maatoug
JJJed Jebali
Jed Jebali
RGRégis Guieu
Régis Guieu
Michel De WaardMichel De Waard
Michel De Waard
RKRIADH KHARRAT
RIADH KHARRAT

1 December 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Oussema KhamessiOussema Khamessi
Oussema Khamessi
HMHazem Ben Mabrouk
Hazem Ben Mabrouk
HOHoucemeddine Othman
Houcemeddine Othman
RERym ElFessi-Magouri
Rym ElFessi-Magouri
Michel De WaardMichel De Waard
Michel De Waard
RKRIADH KHARRAT
RIADH KHARRAT

26 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
EREl Fessi Rym
El Fessi Rym
Oussema KhamessiOussema Khamessi
Oussema Khamessi
NSNajet Srairi-Abid
Najet Srairi-Abid
Jean-Marc SabatierJean-Marc Sabatier
Jean-Marc Sabatier
JTJan Tytgat
Jan Tytgat
RKRIADH KHARRAT
RIADH KHARRAT
Scorpion venom is a rich source of promising therapeutic compounds, such as highly selective ion channel ligands with potent pharmacological effects. Bot33 is a new short polypeptide of 38 amino acid residues with six cysteines purified from the venom of the Buthus occitanus tunetanus scorpion. Bot33 has revealed less than 40% identity with other known alpha-KTx families. This peptide displayed a neutral amino acid (Leucine), in the position equivalent to lysine 27, described as essential for the interaction with Kv channels. Bot33 did not show any toxicity following i.c.v. injection until 2 µg/kg mouse body weight. Due to its very low venom concentration (0.24%), Bot33 was chemically synthesized. Unexpectedly, this peptide has been subjected to a screening on ion channels expressed in Xenopus laevis oocytes, and it was found that Bot33 has no effect on seven Kv channel subtypes. Interestingly, an in silico molecular docking study shows that the Leu27 prevents the interaction of Bot33 with the Kv1.3 channel. All our results indicate that Bot33 may have a different mode of action from other scorpion toxins, which will be interesting to elucidate.

31 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Oussema KhamessiOussema Khamessi
Oussema Khamessi
HMHazem Ben Mabrouk
Hazem Ben Mabrouk
SKSelim Kamoun
Selim Kamoun
CHChaima Hkimi
Chaima Hkimi
KGKais Ghedira
Kais Ghedira
RKRIADH KHARRAT
RIADH KHARRAT
Snake venom contains a number of active molecules that have been shown to possess high anti-tumor activities; disintegrins are an excellent example among these. Their ability to interact and bind with integrins suggests that they could be very valuable molecules for the development of new cancer therapeutic approaches. However, in the absence of a clear Lysine-Threonine-Serine (KTS) Disintegrins Integrin interaction model, the exact compound features behind it are still unknown. In this study, we investigated the structural characteristics of three KTS-disintegrins and the interaction mechanisms with the α1β1 integrin receptor using in silico bioinformatics approaches. Normal mode analysis showed that the flexibility of the KTSR motif and the C-terminal region play a key role and influence the KTS-Disintegrin-integrin interaction. Protein-protein docking also suggested that the interaction involving the KTSR motif is highly dependent on the residue following K21, S23 and R24. These findings contribute to a better understanding of the KTS-Disintegrin-Integrin structural differences and their interactions with α1β1 receptors, which could improve the selection process of the best active molecules for antitumor therapies.

30 September 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ZMZEINEB MARZOUGUI
ZEINEB MARZOUGUI
SHSylvie Huet
Sylvie Huet
ABAnne-Louise Blier
Anne-Louise Blier
LHLudovic Le Hegarat
Ludovic Le Hegarat
HTHaïfa Tounsi-Kettiti
Haïfa Tounsi-Kettiti
VFValerie Fessard
Valerie Fessard
The contaminant responsible for the atypical toxicity reported in mussels from Bizerte Lagoon (Northern Tunisia) during the last decade has been characterized as C17-sphinganine analog mycotoxin (C17-SAMT). This neurotoxin showed common mouse toxic symptoms, including flaccid paralysis and severe dyspnea, followed by rapid death. For hazard assessment on human health, in this work we aimed to evaluate the in vivo genotoxic effects of this marine biotoxin using the classical alkaline and modified Fpg comet assays performed to detect DNA breaks and alkali-labile sites as well as oxidized bases. The micronucleus assay was used on bone marrow to detect chromosome and genome damage. C17-SAMT induces a statistically insignificant increase in DNA tail intensity at all doses in the duodenum, and in the spleen contrary to the liver, the percentage of tail DNA increased significantly at the mid dose of 300 µg/kg b.w/d. C17-SAMT did not affect the number of micronuclei in the bone marrow. Microscopic observations of the liver showed an increase in the number of mitosis and hepatocytes’ cytoplasm clarification. At this level of study, we confirm that C17-SAMT induced DNA damage in the liver but there was no evidence of effects causing DNA oxidation or chromosome and genome damage.
1